Clinical Trials
3 trialsNCT02504489 2026-05-19
DUBLIN-3
BeyondSpring Pharmaceuticals Inc.
Phase 3 Completed
NCT07361484 2026-01-23
Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)
BeyondSpring Pharmaceuticals Inc.
Phase 3 Not yet recruiting
NCT02812667 2025-11-12
Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)
University of California, San Diego
Phase 1 Completed